Biomaterials Firm Bolt Threads, Formerly A Unicorn, Plans SPAC Deal At A $250 Million Valuation
CEO Dan Widmaier talks exclusively with Forbes about going public and the ups and downs of running a synthetic biology firm.
Stay updated with breaking news from Bolt Projects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CEO Dan Widmaier talks exclusively with Forbes about going public and the ups and downs of running a synthetic biology firm.
>> the city worked if us for about five years trying to find space for our expansion. >> if you're going to run a world-class brewery you need to meet often with the person who has a finger on the pulse of your operation, and that's the brew meister. today steve hindy is doing just that. >> you're the boss. you sit in this chair. >> yes, i know. >> he's meeting star employee garrett oliver, the authority on all things beer-related. on the cards, a new and improved beer card that will ease the work flow. >> i want to get a tank which will be specifically for kasking and doing all of our little ...